Living Drugs

Saxonian Precision Therapy Cluster

About Us

We are an association of leading research institutes and medical facilities from Saxony, including those in Leipzig, Dresden and Chemnitz.

Learn more on next page

Our Research

A total of 7 research projects and 1 management project for the production of allogeneic cell therapeutics from multiple donors in larger batches at a lower price as well as automation play an important role.

Learn more on next page

News & Press

All events, news and information about our SaxoCell cluster

Learn more on next page

Collaboration & Transfer

Overview of all technology and service offers as well as opportunities for cooperation with SaxoCell

Learn more on next page

Development of novel gene and cell therapeutics

SaxoCell has set itself the goal of developing novel gene and cell therapeutics, so-called “living drugs”, which enable this complex form of therapy to be used more widely in various areas of medicine.
The focus is on the efficacy and tolerability of these new cell therapeutics. In addition, allogeneic therapy approaches and automated manufacturing processes should enable socially acceptable costs.
The technologies developed in the cluster are developed together with local company partners and therefore represent an incentive for investors and corresponding industrial partners to get involved in the cluster region.